DXCM
$122.57
Dexcom
$2.99
2.50%
DXCM
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  $0.22
Revenue:  $840.87 Mil
Thursday
Jul 27
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, April 27, 2023

What do you expect when DXCM reports earnings?
Beat
Meet
Miss

Where is DXCM's stock price going from here?
Up
Flat
Down
Stock chart of DXCM
Analysts
Summary of analysts' recommendations for DXCM
Score
Grade
Pivots
Resistance
$128.21
$125.52
$124.05

$121.36

Support
$119.89
$117.20
$115.73
Tweet
Growth
Description
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Peers
StrykerAbbottBoston ScientificBaxter InternationalTeleflexBecton, Dickinson3MWatersResMedIntegra LifeSciences Holdings